完整的血清,凝血生物标志物和肺功能在COVID-19危急后6个月
Salla Kattainen1, Hanna Pitkänen1, Jere Reijula2
1Division of Intensive Care, Department of Perioperative and Intensive Care Medicine, University of Helsinki and HUS Helsinki University Hospital, Helsinki, Finland.
Acta anaesthesiologica Scandinavica
|May 9, 2024
概括
在危急的COVID-19后六个月,大多数患者表现出异常的凝血生物标志物,因子VIII (FVIII) 的升高与肺扩散能力的降低有关. 这表明正在进行的凝血问题会影响COVID-19后的恢复.
科学领域:
- 临界护理医学 临界护理医学
- 肺部病理学 肺部病理学
- 血液学 血液学 血液学
背景情况:
- 在COVID-19后,器官功能障碍的恢复至关重要.
- 在严重疾病后评估长期凝血状况至关重要.
- 需要了解COVID-19后凝血和肺功能之间的联系.
研究的目的:
- 为了评估凝血生物标志物在COVID-19后6个月的恢复.
- 为了研究凝血状态和肺功能 (DLCOc%) 之间的关联,在COVID-19危急后6个月.
主要方法:
- 在住院6个月后,对ICU治疗的COVID-19患者的完整血清 (CBC) 和凝血生物标志物的分析.
- 6个月值与急性阶段水平的比较.
- 凝血生物标志物与肺功能测试 (PFTs) 的相关性,特别是DLCOc%,使用线性回归.
主要成果:
- 只有21%的患者在6个月后将所有凝血生物标志物正常化.
- 第八因子 (FVIII) 在46%的患者中仍然升高.
- 在DLCOc%和FVIII之间观察到微弱的负相关性,表明肺功能受损.
结论:
- 危急的COVID-19幸存者经常表现出持续的凝血异常,在出院6个月后.
- 在这些患者中,高FVIII水平可能与肺扩散能力 (DLCOc%) 的降低有关.
- 凝血失调可能会导致严重的COVID-19后的长期肺部继发症.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
141
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
141
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
80
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
80
Pneumonia III: Complications and Assessment
203
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
203


